AstraZeneca Pharma India informs about disclosure

21 Jun 2024 Evaluate

With reference to earlier communication dated November 16, 2023, AstraZeneca Pharma India has informed that the Company has completed the exploration phase for search of a buyer who could act as a Contract Manufacturing Organisation and was unable to find a suitable one. The Company will now explore a buyer for its manufacturing site and exit in due course. The Company remains committed to advance access to innovative medicines in India, with a clear ambition to be pioneers in science, lead in specialist disease areas, and transform patient outcomes. The Company is fully cognizant of the impact this change can bring and its first responsibility will be towards its employees and meeting the needs of its patients by ensuring an uninterrupted supply of medicines.

The above information is a part of company’s filings submitted to BSE.

Astrazeneca Pharma I Share Price

9211.50 22.60 (0.25%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×